• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者的钾排泄处理:伴或不伴高钾血症患者之间的差异。

Renal potassium handling in chronic kidney disease: Differences between patients with or wihtout hyperkalemia.

机构信息

Servicio Nefrología, Hospital Infanta Cristina, Badajoz, España.

Servicio Nefrología, Hospital Infanta Cristina, Badajoz, España.

出版信息

Nefrologia (Engl Ed). 2020 Mar-Apr;40(2):152-159. doi: 10.1016/j.nefro.2019.04.011. Epub 2019 Jul 25.

DOI:10.1016/j.nefro.2019.04.011
PMID:31353054
Abstract

INTRODUCTION

Hyperkalemia (HK) is a common electrolyte disorder in chronic kidney disease (CKD), mainly in the advanced stages. A positive potassium balance due to reduced renal excretory capacity is likely the main pathogenic mechanism of HK. Research into the relative role of each pathogenic element in the development of HK in CKD may help to implement more suitable therapies.

OBJECTIVE

To investigate renal potassium handling in advanced CKD patients, and to determine the differences between patients with or without HK.

MATERIAL AND METHODS

Cross-sectional observational study in adult patients with stage 4-5 CKD pre-dialysis. Selection criteria included clinically stable patients and the ability to collect a 24hour urine sample correctly. Blood and urinary biochemical parameters were analysed including sodium and potassium (K). Fractional excretion of K (FEK) and K load relative to glomerular filtration (Ku/GFR) were calculated. HK was defined as a serum K concentration ≥5.5mmol/l.

RESULTS

The study group consisted of 212 patients (mean age 65±14 years, 92 females) with a mean GFR of 15.0±4.2ml/min/1.73m. 63 patients (30%) had HK. Patients with HK had lower mean bicarbonate levels with respect to patients with normal K levels (NK) (20.3±3.1 vs. 22.8±3.2 mEq/l, P<.0001), but no differences were noted in total urinary sodium and K excretion. While mean FEK values were lower in patients with HK (32.1±12.1% vs. 36.4±14.3%, P=.038), Ku/GFR values were significantly greater with respect to the NK subgroup (4.2±1.5 vs. 3.7±1.4 mmol/ml/min, P=0,049). FEK showed a strong linear correlation with Ku/GFR (R=0.74), and partial linear regressions demonstrated that at a similar Ku/GFR level, the FEK of patients with HK was lower than that of NK patients. By multivariate linear and logistic regression analyses, both FEK and Ku/GFR were shown to be the main determinants of K serum levels and HK.

CONCLUSIONS

Although the K load relative to glomerular filtration (Ku/GFR) is an important determinant of HK in advanced CKD, the most noteworthy characteristic associated with HK in these patients was the limitation of compensatory urinary K excretion, as indicated by lower FEK.

摘要

简介

高钾血症(HK)是慢性肾脏病(CKD)中的一种常见电解质紊乱,主要发生在晚期。由于肾脏排泄能力降低导致的钾正平衡可能是 HK 的主要发病机制。研究 CKD 中每个发病因素在 HK 发展中的相对作用,可能有助于实施更合适的治疗方法。

目的

研究晚期 CKD 患者的肾脏钾处理情况,并确定有或无 HK 的患者之间的差异。

材料和方法

对接受透析前 4-5 期 CKD 的成年患者进行横断面观察性研究。入选标准包括临床稳定的患者和能够正确收集 24 小时尿液样本。分析血液和尿液生化参数,包括钠和钾(K)。计算钾的分数排泄(FEK)和 K 负荷与肾小球滤过率(Ku/GFR)的比值。HK 定义为血清 K 浓度≥5.5mmol/l。

结果

研究组共 212 例患者(平均年龄 65±14 岁,92 例女性),平均 GFR 为 15.0±4.2ml/min/1.73m。63 例(30%)患者有 HK。与血清 K 水平正常(NK)的患者相比,HK 患者的平均碳酸氢盐水平较低(20.3±3.1 vs. 22.8±3.2 mEq/l,P<.0001),但总尿钠和 K 排泄无差异。虽然 HK 患者的平均 FEK 值较低(32.1±12.1% vs. 36.4±14.3%,P=.038),但 Ku/GFR 值明显大于 NK 亚组(4.2±1.5 vs. 3.7±1.4 mmol/ml/min,P=0.049)。FEK 与 Ku/GFR 呈强线性相关(R=0.74),偏线性回归显示在相似的 Ku/GFR 水平下,HK 患者的 FEK 低于 NK 患者。多元线性和逻辑回归分析表明,FEK 和 Ku/GFR 均为血清 K 水平和 HK 的主要决定因素。

结论

尽管肾小球滤过率相关的钾负荷(Ku/GFR)是晚期 CKD 中 HK 的一个重要决定因素,但这些患者中与 HK 相关的最显著特征是代偿性尿钾排泄受限,表现为 FEK 降低。

相似文献

1
Renal potassium handling in chronic kidney disease: Differences between patients with or wihtout hyperkalemia.慢性肾脏病患者的钾排泄处理:伴或不伴高钾血症患者之间的差异。
Nefrologia (Engl Ed). 2020 Mar-Apr;40(2):152-159. doi: 10.1016/j.nefro.2019.04.011. Epub 2019 Jul 25.
2
Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.高钾血症与晚期慢性肾脏病临床结局的关联
Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):513-522. doi: 10.1016/j.nefro.2019.01.007. Epub 2019 Apr 23.
3
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].[晚期慢性肾脏病中的电解质和酸碱平衡紊乱]
Nefrologia. 2008;28 Suppl 3:87-93.
4
The Association of Urinary Sodium and Potassium with Renal Uric Acid Excretion in Patients with Chronic Kidney Disease.慢性肾脏病患者尿钠和钾与肾脏尿酸排泄的关系
Kidney Blood Press Res. 2018;43(4):1310-1321. doi: 10.1159/000492590. Epub 2018 Aug 10.
5
Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.低清除率门诊随访的透析前患者高钾血症的患病率及相关因素。
Clin J Am Soc Nephrol. 2012 Aug;7(8):1234-41. doi: 10.2215/CJN.01150112. Epub 2012 May 17.
6
The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD).尿钠与钾的比值和慢性肾脏病进展:韩国慢性肾脏病患者结局队列研究(KNOW-CKD)的结果
Medicine (Baltimore). 2018 Nov;97(44):e12820. doi: 10.1097/MD.0000000000012820.
7
Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.在慢性肾脏病中,很难成功纠正代谢性酸中毒。
Nefrologia (Engl Ed). 2020 May-Jun;40(3):328-335. doi: 10.1016/j.nefro.2019.09.006. Epub 2019 Dec 18.
8
Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.慢性肾脏病患者血钾水平升高:一项丹麦基于人群的队列研究中的发生、危险因素和临床结局。
Nephrol Dial Transplant. 2018 Sep 1;33(9):1610-1620. doi: 10.1093/ndt/gfx312.
9
Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care.非透析 CKD 患者高钾血症的当前管理:接受稳定肾脏护理的患者的纵向研究。
Nutrients. 2021 Mar 15;13(3):942. doi: 10.3390/nu13030942.
10
Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?膳食钾摄入与慢性肾脏病患者高钾血症有关吗?
Nephrol Dial Transplant. 2021 Nov 9;36(11):2049-2057. doi: 10.1093/ndt/gfaa232.

引用本文的文献

1
Understanding Renal Tubular Function: Key Mechanisms, Clinical Relevance, and Comprehensive Urine Assessment.了解肾小管功能:关键机制、临床相关性及全面尿液评估。
Pathophysiology. 2025 Jul 3;32(3):33. doi: 10.3390/pathophysiology32030033.
2
Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study).高钾血症与新型钾结合剂的使用:来自挪威韦斯特福尔郡的单中心经验(PotBind研究)
Int J Nephrol Renovasc Dis. 2023 Mar 16;16:73-82. doi: 10.2147/IJNRD.S401623. eCollection 2023.
3
Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice.
内分泌学实践中获得性醛固酮减少症的临床表现及相关因素。
Front Endocrinol (Lausanne). 2022 Oct 11;13:990148. doi: 10.3389/fendo.2022.990148. eCollection 2022.
4
Estimation of Potassium Changes Following Potassium Supplements in Hypokalemic Critically Ill Adult Patients-A Patient Personalized Practical Treatment Formula.低钾血症危重症成年患者补钾后钾变化的估计——一种患者个体化的实用治疗公式
J Clin Med. 2021 May 5;10(9):1986. doi: 10.3390/jcm10091986.